STOCK TITAN

OSR Health director receives 120,000-share award

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

OSR Health, Inc. director Seng Chin Mah received a fully vested stock award of 120,000 shares on October 29, 2026, under the 2025 Omnibus Incentive Plan. The award is subject to a six-month contractual lock-up from the grant date.

Insider Mah Seng Chin
Role Director
Type Security Shares Price Value
Grant/Award OSRH F1 120,000 $0.00 $0.00
Holdings After Transaction: OSRH — 120,000 shares (Direct)
Holdings Before and After: OSRH, 0 to 120,000 shares (Direct)
Footnotes (1)
  1. F1. Represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan. The shares are subject to a six-month contractual lock-up from the grant date.
Shares awarded 120,000 shares Fully vested award granted October 29, 2026
Direct holdings following award 120,000 shares Reported position after the award
fully vested stock award financial
"Represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan"
Omnibus Incentive Plan financial
"granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
contractual lock-up technical
"subject to a six-month contractual lock-up from the grant date"
A contractual lock-up is an agreement that prevents certain shareholders from selling or transferring their shares for a specified period after a corporate event, such as an initial public offering or a merger. It matters to investors because it temporarily limits how many shares can come onto the market—think of it as a timed lockbox—and when the restriction ends there can be added selling pressure that may affect the stock's supply and price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many OSRH shares did director Seng Chin Mah receive?

Seng Chin Mah received a fully vested stock award of 120,000 shares on October 29, 2026. It was granted under the 2025 Omnibus Incentive Plan and is subject to a six-month contractual lock-up from the grant date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mah Seng Chin

(Last)(First)(Middle)
10900 NE 4TH STREET, SUITE 2300

(Street)
BELLEVUE WASHINGTON 98004

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
OSR Health, Inc. [ OSRH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/29/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
OSRH10/29/2026A120,000(1)A$0120,000D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents a fully vested stock award granted under the OSR Health, Inc. 2025 Omnibus Incentive Plan. The shares are subject to a six-month contractual lock-up from the grant date.
Remarks:
Power of Attorney previously filed as Exhibit 24 to the reporting person's Form 3 filed on November 18, 2026.
/s/ Timothy Clement Smith, Attorney-in-Fact for Seng Chin Mah11/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading